Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China-Reference-Cited by-同舟云学术

Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China

Published:2020-08 Issue:4 Volume:19 Page:349-357
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Zhan Qi-Fan,Ling Sun-Bin,Deng Yi-Nan,Shan Qiao-Nan,Ye Qian-Wei,Xu Sheng-Jun,Jiang Guang-Jiang,Lu Di,Wei Xu-Yong,Zhuang Li,Zhang Wu,Shen Tian,Cen Bei-Ni,Xie Hai-Yang,Liu Ji-Min,Wu Jian,Zheng Shu-Sen,Yang Yang,Xu Xiao

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma;Pinna;Ann Surg,2018

4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

5. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience;Mazzaferro;Liver Transpl,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options;Transplantation Proceedings;2024-07

2. Evolution of Liver Transplantation Indications: Expanding Horizons;Medicina;2024-02-28

3. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China;Cancer Biology & Medicine;2024-02-28

4. Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features;BMC Cancer;2023-09-12

5. BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy;Cancer Letters;2023-09